176 related articles for article (PubMed ID: 17276673)
1. Overexpression of LAPTM4B-35 closely correlated with clinicopathological features and post-resectional survival of gallbladder carcinoma.
Zhou L; He XD; Chen J; Cui QC; Qu Q; Rui JA; Zhao YP
Eur J Cancer; 2007 Mar; 43(4):809-15. PubMed ID: 17276673
[TBL] [Abstract][Full Text] [Related]
2. LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma.
Yang Y; Yang H; McNutt MA; Xiong F; Nie X; Li L; Zhou R
Oncol Rep; 2008 Nov; 20(5):1077-83. PubMed ID: 18949404
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of LAPTM4B promotes growth of gallbladder carcinoma cells in vitro.
Zhou L; He XD; Yu JC; Zhou RL; Yang H; Qu Q; Rui JA
Am J Surg; 2010 Apr; 199(4):515-21. PubMed ID: 19954766
[TBL] [Abstract][Full Text] [Related]
4. Expression of LAPTM4B in gallbladder carcinoma cells: the role in invasive potential.
Zhou L; He XD; Yu JC; Zhou RL; Xiong FX; Qu Q; Rui JA
Hepatogastroenterology; 2010; 57(98):207-11. PubMed ID: 20583413
[TBL] [Abstract][Full Text] [Related]
5. LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma.
Yang H; Xiong F; Qi R; Liu Z; Lin M; Rui J; Su J; Zhou R
J Surg Oncol; 2010 Apr; 101(5):363-9. PubMed ID: 20358632
[TBL] [Abstract][Full Text] [Related]
6. Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma.
Zhou L; He XD; Cui QC; Zhou WX; Qu Q; Zhou RL; Rui JA; Yu JC
Cancer Lett; 2008 Jun; 264(2):209-17. PubMed ID: 18334282
[TBL] [Abstract][Full Text] [Related]
7. Astrocyte elevated gene-1 overexpression in human primary gallbladder carcinomas: an unfavorable and independent prognostic factor.
Sun W; Fan YZ; Xi H; Lu XS; Ye C; Zhang JT
Oncol Rep; 2011 Nov; 26(5):1133-42. PubMed ID: 21750868
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of retinoblastoma protein predicts decreased survival and correlates with loss of p16INK4 protein in gallbladder carcinomas.
Shi YZ; Hui AM; Li X; Takayama T; Makuuchi M
Clin Cancer Res; 2000 Oct; 6(10):4096-100. PubMed ID: 11051262
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of LAPTM4B-35 is associated with poor prognosis in colorectal carcinoma.
Kang Y; Yin M; Jiang W; Zhang H; Xia B; Xue Y; Huang Y
Am J Surg; 2012 Nov; 204(5):677-83. PubMed ID: 22578410
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of clinicopathological significance, BIRC7, and STC2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
Yuan Y; Yang ZL; Zou Q; Li JH; Li DQ; Liang LF; Zeng GX; Chen SL
Neoplasma; 2013; 60(6):698-705. PubMed ID: 23906305
[TBL] [Abstract][Full Text] [Related]
11. Gender-specific prognostic markers of patients with gallbladder cancer after surgical resection.
He XD; Liu W; Tao LY; Cai L; Zhou L; Qu Q
Am Surg; 2010 Nov; 76(11):1269-74. PubMed ID: 21140697
[TBL] [Abstract][Full Text] [Related]
12. Syndecan-1 expression in gallbladder cancer and its prognostic significance.
Roh YH; Kim YH; Choi HJ; Lee KE; Roh MS
Eur Surg Res; 2008; 41(2):245-50. PubMed ID: 18544939
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma.
Shao GZ; Zhou RL; Zhang QY; Zhang Y; Liu JJ; Rui JA; Wei X; Ye DX
Oncogene; 2003 Aug; 22(32):5060-9. PubMed ID: 12902989
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of cell cycle-related molecules in gastric carcinoma: prognostic significance, correlation with clinicopathological parameters, proliferation and apoptosis.
Lee KH; Lee HE; Cho SJ; Cho YJ; Lee HS; Kim JH; Nam SY; Chang MS; Kim WH; Lee BL
Pathobiology; 2008; 75(6):364-72. PubMed ID: 19096232
[TBL] [Abstract][Full Text] [Related]
15. Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma. A systematic analysis including primary and corresponding metastatic tumours.
Kornprat P; Rehak P; Rüschoff J; Langner C
J Clin Pathol; 2006 Feb; 59(2):202-6. PubMed ID: 16443739
[TBL] [Abstract][Full Text] [Related]
16. Correlation between MMP1-PAR1 axis and clinical outcome of primary gallbladder carcinoma.
Du X; Wang S; Lu J; Cao Y; Song N; Yang T; Dong R; Zang L; Yang Y; Wu T; Li J
Jpn J Clin Oncol; 2011 Sep; 41(9):1086-93. PubMed ID: 21835828
[TBL] [Abstract][Full Text] [Related]
17. Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancer.
Roh YH; Kim YH; Choi HJ; Lee KE; Roh MS
J Hepatobiliary Pancreat Surg; 2009; 16(3):315-21. PubMed ID: 19259612
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of LAPTM4B-35 attenuates epirubucin-induced apoptosis of gallbladder carcinoma GBC-SD cells.
Zhou L; He XD; Yu JC; Zhou RL; Shan Y; Rui JA
Surgery; 2011 Jul; 150(1):25-31. PubMed ID: 21429547
[TBL] [Abstract][Full Text] [Related]
19. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
20. Heparanase expression in gallbladder carcinoma and its correlation to prognosis.
Wu W; Pan C; Yu H; Gong H; Wang Y
J Gastroenterol Hepatol; 2008 Mar; 23(3):491-7. PubMed ID: 17524042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
